ERAS
Erasca, Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.09
−1.03%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+34.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 12, 2026 | Fuchs Charles S. · officer: President, R&D | A-Award | 1,300,000 | $18 |
| Jun 29, 2026 | Hambleton Julie · director | A-Award | 29,888 | $16 |
| Jun 29, 2026 | Bristol James Arthur · director | A-Award | 29,888 | $16 |
| Jun 29, 2026 | Casdin Alexander W. · director | A-Award | 29,888 | $16 |
| Jun 29, 2026 | Start Valerie Denise Harding · director | A-Award | 29,888 | $16 |
| Jun 29, 2026 | LIU JEAN I · director | A-Award | 29,888 | $16 |
| Jun 29, 2026 | Multani Pratik S · director | A-Award | 29,888 | $16 |
| Apr 3, 2026 | Garner Ebun · officer: Chief Legal Officer | Sale | 80,000 | $16 |
| Apr 3, 2026 | Garner Ebun · officer: Chief Legal Officer | M-Exempt | 80,000 | $1.70 |
| Mar 6, 2026 | Morris Shannon · officer: Chief Medical Officer | M-Exempt | 20,000 | $1.70 |
| Mar 6, 2026 | Morris Shannon · officer: Chief Medical Officer | Sale | 20,000 | $15 |
| Jan 30, 2026 | Chacko David M. · officer: CFO and CBO | A-Award | 640,000 | $10 |
| Jan 30, 2026 | Garner Ebun · officer: General Counsel & Corp. Sec. | A-Award | 560,000 | $10 |
| Jan 30, 2026 | Lim Jonathan E · director, 10 percent owner, officer: Chairman & CEO | A-Award | 2,000,000 | $10 |
| Jan 30, 2026 | Morris Shannon · officer: Chief Medical Officer | A-Award | 625,000 | $10 |
| Jan 30, 2026 | Varney Michael David · director | A-Award | 96,000 | $10 |
| Jan 8, 2026 | Garner Ebun · officer: General Counsel & Corp. Sec. | Sale | 120,000 | $5.59 |
| Jan 8, 2026 | Garner Ebun · officer: General Counsel & Corp. Sec. | M-Exempt | 120,000 | $1.70 |
| Jan 8, 2026 | Garner Ebun · officer: General Counsel & Corp. Sec. | A-Award | 3,902 | $1.19 |
| Jan 5, 2026 | Start Valerie Denise Harding · director | A-Award | 24,306 | $3.72 |
| Jan 5, 2026 | Casdin Alexander W. · director | A-Award | 23,872 | $3.72 |
| Jan 5, 2026 | Bristol James Arthur · director | A-Award | 37,762 | $3.72 |
| Jan 5, 2026 | LIU JEAN I · director | A-Award | 20,617 | $3.72 |
| Jan 5, 2026 | Multani Pratik S · director | A-Award | 19,532 | $3.72 |
| Jun 26, 2025 | LIU JEAN I · director | A-Award | 120,000 | $1.45 |
| Jun 26, 2025 | Start Valerie Denise Harding · director | A-Award | 120,000 | $1.45 |
| Jun 26, 2025 | Multani Pratik S · director | A-Award | 120,000 | $1.45 |
| Jun 26, 2025 | Bristol James Arthur · director | A-Award | 120,000 | $1.45 |
| Jun 26, 2025 | Casdin Alexander W. · director | A-Award | 120,000 | $1.45 |
| Jun 26, 2025 | Hambleton Julie · director | A-Award | 120,000 | $1.45 |
Institutional positioning
13F filings over the trailing two quarters
New 162Increased 182Reduced 118Sold out 27
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | Increased | 24,975,188 | Aug 14, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Increased | 24,675,188 | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 21,259,646 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 21,185,839 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 21,154,146 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 20,151,406 | May 13, 2026 |
| RTW INVESTMENTS, LP | Increased | 17,946,754 | Aug 14, 2026 |
| VR Adviser, LLC | Increased | 17,891,812 | Aug 14, 2026 |
| VR ADVISER, LLC | Reduced | 16,382,812 | May 15, 2026 |
| RTW INVESTMENTS, LP | Increased | 16,157,175 | May 15, 2026 |
| STATE STREET CORP | Increased | 12,184,555 | Aug 7, 2026 |
| VIVO CAPITAL, LLC | Increased | 12,151,480 | May 20, 2026 |
| Logos Global Management LP | Increased | 12,150,000 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 11,402,199 | Aug 13, 2026 |
| Siren, L.L.C. | Increased | 11,397,781 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 12, 2026